Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
<p>Abstract</p> <p>Background</p> <p>This study was aimed 1) to investigate the predictive value of FDG PET/CT (fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography) for histopathologic response and 2) to explore the results of FDG PET/CT by m...
Main Authors: | Han Wonshik, Kim Jee, Cho Nariya, Oh Do-Youn, Han Sae-Won, Koh Youngil, Im Seock-Ah, Keam Bhumsuk, Kang Keon, Moon Woo, Kim Tae-You, Park In, Noh Dong-Young, Chung June-Key, Bang Yung-Jue |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/11/452 |
Similar Items
-
Early Prediction of Tumor Response to Neoadjuvant Chemotherapy and Clinical Outcome in Breast Cancer Using a Novel FDG-PET Parameter for Cancer Stem Cell Metabolism
by: Chanwoo Kim, et al.
Published: (2020-09-01) -
[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
by: Giulia Polverari, et al.
Published: (2020-10-01) -
[18F]FDG-PET/CT in prone compared to supine position for optimal axillary staging and treatment in clinically node-positive breast cancer patients with neoadjuvant systemic therapy
by: Ariane A. van Loevezijn, et al.
Published: (2021-08-01) -
Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
by: Mette S. van Ramshorst, et al.
Published: (2017-05-01) -
Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
by: Xin Xu, et al.
Published: (2021-07-01)